---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-277335"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2021-09-20T23:59:59+00:00"
generated_at: "2026-06-29T02:40:11.669320+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte appoints Annie Drapeau and Teri Loxam to board; Heron and Hopfner resign

## Summary
- Directors Patrick Heron and Rob Hopfner resigned effective Sept 16, 2021, not due to any disagreement.
- Annie Drapeau and Teri Loxam appointed as Class I directors with terms expiring at 2024 annual meeting.
- Drapeau joins Compensation and Nominating Committees; Loxam joins Audit Committee.
- Each new director receives initial option for 30,000 shares vesting over 3 years, annual option for 15,000 shares, and cash retainers ($40,000 base plus committee fees).

## SEC filing metadata
- accession: 0001193125-21-277335
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2021-09-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000119312521277335/0001193125-21-277335-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000119312521277335/d234071d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-277335
- JSON: https://secwatch.observer/filing/0001193125-21-277335.json
- Plain text: https://secwatch.observer/filing/0001193125-21-277335.txt

## Key facts
- Executive change
  Patrick Heron resigned as Director at Vaxcyte, Inc..
  - Action: resigned
  - Role: Director
  source text: On September 16, 2021, Patrick Heron, a director of the Vaxcyte, Inc. (the “Company”) and member of the Audit Committee, and Rob Hopfner, a director of the Company and member of the Nominating and Corporate Governance Committee (the “Nominating Committee”), both resigned as members of the Company’s Board of Directors (the “Board”), which resignations became effective on September 16, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649094/000119312521277335/0001193125-21-277335-index.htm
- Executive change
  Teri Loxam was appointed as Director at Vaxcyte, Inc..
  - Action: appointed
  - Role: Director
  source text: On September 16, 2021, upon recommendation of the Nominating Committee, the Board appointed Annie Drapeau and Teri Loxam to the Board as Class I directors, which appointments became effective on September 16, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649094/000119312521277335/0001193125-21-277335-index.htm
- Executive change
  Rob Hopfner resigned as Director at Vaxcyte, Inc..
  - Action: resigned
  - Role: Director
  source text: On September 16, 2021, Patrick Heron, a director of the Vaxcyte, Inc. (the “Company”) and member of the Audit Committee, and Rob Hopfner, a director of the Company and member of the Nominating and Corporate Governance Committee (the “Nominating Committee”), both resigned as members of the Company’s Board of Directors (the “Board”), which resignations became effective on September 16, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649094/000119312521277335/0001193125-21-277335-index.htm
- Executive change
  Annie Drapeau was appointed as Director at Vaxcyte, Inc..
  - Action: appointed
  - Role: Director
  source text: On September 16, 2021, upon recommendation of the Nominating Committee, the Board appointed Annie Drapeau and Teri Loxam to the Board as Class I directors, which appointments became effective on September 16, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649094/000119312521277335/0001193125-21-277335-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.